Michael J. Willisch
Lawyers
Filters
Cellnex Telecom €4 billion equity offering
Davis Polk advised Cellnex Telecom, S.A. as to U.S. law in connection with its offering of 101,382,140 new ordinary shares pursuant to a public rights offering in Spain and private…
Oryzon Genomics €20 million private placement
Davis Polk advised Oryzon Genomics, S.A. on its private placement of approximately 7,273,000 of its ordinary shares pursuant to a capital increase. The offering consisted of two tranches: a…
BBVA €1.1 billion asset-backed notes offering
Davis Polk advised Banco Bilbao Vizcaya Argentaria, S.A. on the offering of asset-backed notes with an aggregate face value amount of approximately €1.1 billion issued by BBVA Consumer Auto…
Davis Polk Advises Enel SpA on Two Share Swap Transactions
Davis Polk advised Enel SpA in connection with its entry into two share swap transactions with a financial institution to increase its equity stake in its listed Chilean subsidiary Enel…
Davis Polk Advises Árima Real Estate SOCIMI, S.A. on Its €150 Million Follow-on Offering
Davis Polk advised Árima Real Estate SOCIMI, S.A. on the Rule 144A/Regulation S follow-on offering by Árima of 14,423,076 of Árima’s ordinary shares, raising gross proceeds of €150 million…
Davis Polk Advises Cellnex Telecom, S.A. on Its €2.5 Billion Equity Offering
Davis Polk advised Cellnex Telecom, S.A. as to U.S. law in connection with its offering of 86,653,476 new ordinary shares pursuant to a public rights offering in Spain and private…
EQT’s Tender Offer for Parques Reunidos
Davis Polk advised the financial adviser to the board of directors of Parques Reunidos Servicios Centrales, S.A. in connection with the voluntary tender offer by Piolin BidCo, S.A.U.,…
Davis Polk Advises BBVA on Its $1 Billion SEC-Registered Preferred Securities Offering
Davis Polk advised Banco Bilbao Vizcaya Argentaria, S.A. on its SEC-registered offering of $1 billion liquidation preference of series 9 non-step-up non-cumulative contingent convertible…
Oryzon Genomics’s Private Placement of Ordinary Shares
Davis Polk advised Oryzon Genomics, S.A. on its €20 million private placement of its ordinary shares pursuant to a capital increase. The offering consisted of a private placement to…
Davis Polk Advises Árima Real Estate SOCIMI, S.A. on Its €40 Million Follow-on Offering
Davis Polk advised Árima Real Estate SOCIMI, S.A. on the Rule 144A/Regulation S follow-on offering by Árima of 4,000,000 of Árima’s ordinary shares, raising gross proceeds of €40 million…